Identifícate
Grupos
Investigadores/as
Resultados
SIDA E INFECCIONES VIH
Lund University
Lund, Suecia
Estás en
Colaboraciones
Lund University
Publicaciones en colaboración con investigadores/as de Lund University (2)
2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2015
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
Contactar
Aviso Legal
Ayuda
translate
es
arrow_drop_down
translate
es
arrow_drop_down
eu
en
fr
de
